Password Protected
Enter Password :
Nope
Yep, that's right!
Skip to content
Search for:
OUR NETWORK
Our Story
Governance
Members
Become a Member
Awareness Events
INITIATIVES
EuroACT
COVID-19 Resources
EU Integration of HTA
Reasonable Legal Agreements
Survey on Fair Market Value
ACADEMY
Evidence-Based Advocacy
Knowledge Base
On-demand Courses
Patients in Publications
Virtual Meetings Resource Center
WECAN Academy
WECAN Science
NEWS
Academy 2023 Recap
Search for:
OUR NETWORK
Our Story
Governance
Members
Become a Member
Awareness Events
INITIATIVES
EuroACT
COVID-19 Resources
EU Integration of HTA
Reasonable Legal Agreements
Survey on Fair Market Value
ACADEMY
Evidence-Based Advocacy
Knowledge Base
On-demand Courses
Patients in Publications
Virtual Meetings Resource Center
WECAN Academy
WECAN Science
NEWS
Academy 2023 Recap
OUR NETWORK
Our Story
Governance
Members
Become a Member
Awareness Events
INITIATIVES
EuroACT
COVID-19 Resources
EU Integration of HTA
Reasonable Legal Agreements
Survey on Fair Market Value
ACADEMY
Evidence-Based Advocacy
Knowledge Base
On-demand Courses
Patients in Publications
Virtual Meetings Resource Center
WECAN Academy
WECAN Science
NEWS
Academy 2023 Recap
WECAN Academy Knowledge Base
Your first Knowledge Base Article
Advocacy Tools & Skills
How to develop good content and patient materials - print, online and video
Financial Management of Non-Profit Patient Organisations
Evidence-Based Patient Advocacy: Creating evidence for advocacy impact
Good NGO governance and ensuring transparency and integrity
Presentations skills: How not to bore your audience to death
Healthcare Systems, Policy & Access
Healthcare ecosystem and stakeholder management
Regulatory system. Overview of access pathways - why is access to treatment, care and diagnostics an issue
Basics of Health Economics
How and why does access to treatment and care differ between EU Member States, and how to address it in advocacy and policy?
Affordability and sustainability. Difference between HTA and payer perspective. What is Europe's challenge? How to influence reimbursement decisions as a patient advocate?
Research & Data
How therapy development works, the development lifecycle, endpoints, trial design, patient engagement in research
Basics of statistics, reading scientific papers and publications
Hot topics in oncology: Precision medicine, immuno-oncology, genomics, big data, real-world-data
Patient-reported outcomes, and other patient-relevant measures and endpoints
Basics of biobanks and registries – types, value, challenges, relevance for patient advocacy
Your first Knowledge Base Article
demo text
Last updated byAnonymous
138
reads
Was this article of help to you?
0
0
0
0
Page load link
Go to Top
